What Lies Ahead for European Cell and Gene Therapies?
Cell and gene therapies have recently made big advances in providing effective treatments for a…
April 18, 2018 - 5 minutes
Cell and gene therapies have recently made big advances in providing effective treatments for a…
Although biotech may seem like an industry that has only just gotten started, it was…
Riccardo Palmisano is CEO of MolMed, the most important Italian biotech, which focuses on gene…
Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian…
MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune…
From one fashion capital to the other, this week we leave Paris and head down…